Maternal inflammation risk factors linked to dysregulation in children

Maternal inflammation risk factors may be associated with dysregulation in children, according to a study funded by the Environmental influences on Child Health Outcomes (ECHO) Program at the National Institutes of Health.

Orthofix hires new CEO, 2 months after former leaders ousted

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Massimo Calafiore, new Orthofix CEO Courtesy of

November 29, 2023

Hologic’s radiographic markers targeted in FDA safety communication

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration

February 28, 2024

IL2-CD25 by Bristol-Myers Squibb for Subacute Cutaneous Lupus Erythematosus (SCLE): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.